跳至主要内容
临床试验/NCT07307326
NCT07307326尚未招募不适用

An Examination of the Feasibility of a Brief Personalized Alcohol Biomarker Feedback Intervention for High-risk College Students

Penn State University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2026年10月15日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
试验地点
1
主要终点
Examine changes in Transdermal Alcohol Concentration (TAC) rise rate

研究概览

简要总结

The goal of the study is to examine alcohol use behaviors of young adults through the use of testing the feasibility of adding an innovative brief personalized alcohol biomarker feedback component (TAC feedback) to an existing efficacious personalized feedback intervention, eCHECKUP TO GO (eCTG), and how (if at all) the intervention impacts drinking behaviors in high-risk college students. The study will conduct a feasibility assessment of the TAC feedback component, and will also assess the effects of the eCTG + TAC at 6-months post-baseline relative to an eCTG only group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 23 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 18-23 at enrollment
  • Endorse drinking 4+/5+ (women/men) on a typical Friday or Saturday in the past 3-months
  • Report at least 1 alcohol-induced blackout in the past 3-months
  • Willing to wear a TAC sensor for 14 days at Waves 1 and 2

排除标准

  • Younger than 18 at baseline
  • Not fluent in English
  • No Internet access

研究组 & 干预措施

eCHECKUP TO GO (eCTG)

Experimental

A brief, web-based program designed by San Diego State University to reduce high-risk drinking by providing personalized normative feedback regarding alcohol use, risk factors, and risks associated with drinking and accurate information about alcohol

干预措施: eCHECKUP TO GO (eCTG) (Behavioral)

eCHECKUPTOGO + brief personalized biomarker feedback intervention (eCTG + TAC)

Experimental

Participants will receive the eCHECKUPTOGO in addition to the transdermal alcohol concentration (TAC) personalized feedback. The TAC is a brief individually delivered intervention based on the principles of Motivational Interviewing and focuses on increasing students' motivation to reduce harmful drinking by drinking in a safer, less risky manner. Participants will receive information on their drinking (both from the TAC sensor and daily diary data). Participants will be asked about drinking events during the past 2 weeks (how reflective they were of typical patterns and if a night stood out as particularly negative). Students will receive information and visual representations about TAC rise rates and peaks, and then be shown how their drinking during the past 2 weeks maps onto those visuals.

干预措施: eCHECKUPTOGO + brief personalized alcohol biomarker feedback intervention (eCTG + TAC) (Behavioral)

结局指标

主要结局

Examine changes in Transdermal Alcohol Concentration (TAC) rise rate

时间窗: Baseline, 6 months

TAC rise rate will be collected via the BACtrack Skyn wrist sensor, which measures transdermal alcohol concentration (TAC) in micrograms of ethanol per liter of air every 20 seconds to obtain biomarkers - rise rate is a TAC increase.

Examine changes in Transdermal Alcohol Concentration (TAC) peak intoxication level

时间窗: Baseline, 6 months

TAC peak will be collected via the BACtrack Skyn wrist sensor, which measures transdermal alcohol concentration (TAC) in micrograms of ethanol per liter of air every 20 seconds to obtain biomarkers - peak is the maximum TAC recorded per day.

Examine high risk drinking days

时间窗: Baseline, 6 months

Heavy episodic drinking (HED) days are recorded when women indicate drinking 4+ drinks in 2 hour window/men indicate drinking 5+ drinks in 2 hour window. High-intensity drinking (HID) days are recorded when women indicate drinking 8+ drinks in 2 hour window/men indicate drinking 10+ drinks in 2 hour window.

次要结局

  • Examine negative consequences of alcohol use(Baseline, 6 months)
  • Examine Alcohol Use Disorder (AUD) symptoms(Baseline, 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kimberly Mallett

Research Professor

Penn State University

研究点 (1)

Loading locations...

相似试验

已完成
1 期
A first-in-man study to compare an investigational ropinirole transdermal patch formulation with a ropinirole oral tablet (Requip [Registered Trademark] XL [Trademark]) in healthy volunteers.Neurological - Parkinson's diseaseParkinson's Disease
ACTRN12612000946819INCResearch Australia Pty Ltd24
招募中
不适用
A prospective, single-arm, single-center, investigator initiated clinical trial to evaluate the safety and effectiveness of a patient- specific bone distraction device that combines a patient-specific bone fixation site and a ready-made distractor for patients who need maxillofacial bone distractioDiseases of the digestive system
KCT0008094Chung-Ang Univerisity Hospital20
尚未招募
不适用
A prospective cohort study to investigate the use of avb3-integrin imaging as a surrogate endpoint for therapeutic interventions in patients with myocardial infarction.
NL-OMON27835Maastricht University Medical Center123
进行中(未招募)
不适用
An open, prospective, single-arm study investigating safety and efficacy of the human hepatitis B immunoglobulin BT088 after subcutaneous application in liver transplanted patientsClinical Phase: III - STUDY 974PROPHYLAXIS OF HEPATITIS B REINFECTION AFTER LIVER TRANSPLANTATIONMedDRA version: 9.1Level: LLTClassification code 10058827Term: Hepatitis B reactivation
EUCTR2008-007625-39-ITBiotest AG130
已完成
不适用
A self-controlled, prospective observational study to evaluate the diagnostic performance of liquid-based cytology (LBC) versus conventional cytology for detecting uterine cervical lesionscervical cancer
JPRN-UMIN000011496School of Medicine, Keio University300